On-Demand DCT Webinars

  1. Navigating Tension Of Clinical Equipoise In Precision Oncology Trials 5/5/2026

    This roundtable discussion examines the tension between legacy methods and modern innovation, exploring the complexities of hybrid trial designs and the changing regulatory landscape.

     

  2. Flexible Supply Strategies For Complex Clinical Trials 3/25/2026

    Explore how demand-led, decentralized clinical supply models are reshaping complex trials by reducing waste, accelerating timelines, and advancing patient-centric access to investigational therapies.

  3. The Pharmacy Advantage In Direct-To-Patient Clinical Supply 3/24/2026

    Understand state pharmacy regulations, prescription requirements, and operational considerations for shipping clinical supplies directly from pharmacies to patients' homes in decentralized trial models.

  4. Optimizing Clinical Supply Flexibility With Demand-Led Strategies 3/24/2026

    Explore demand-led supply strategies for clinical trials. Compare traditional vs. DLS models and learn when pack-to-order, pack-to-stock, or hybrid approaches optimize supply flexibility.

  5. Real-World DHT Adherence Insights And Good Practices 7/10/2025

    While advances in sensors and device design are improving wearability, successful data collection still hinges on participant adherence. The session highlights why addressing this can’t be an afterthought.

  6. Inspection Readiness For Decentralized Trials 3/31/2025

    Decentralized Clinical Trials (DCTs) enhance research inclusivity by minimizing logistical barriers such as travel, scheduling conflicts, and costs, making participation more accessible.

  7. A Framework For Selecting Reliable Clinical Endpoints From Real-World DHT Data 2/25/2025

    Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.

  8. Digital Physical Activity Measures In Phase 3 Immunology Trials 2/25/2025

    Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.

  9. Leveraging DHTs To Improve Data Collection And Analysis 2/25/2025

    How can wearable DHTs be leveraged to measure physical activity in patients with immunological diseases, enhancing clinical trials and advancing drug development?

  10. Step Inside IQVIA One Home for Sites™ 1/28/2025

    Whether you're a sponsor, site, or technology vendor, now is the time to embrace One Home and join this industry-wide collaboration.